Azadeh Kia is currently serving as the Vice President Gene Therapy Research at Beacon Therapeutics. Prior to this, Azadeh held positions such as Senior Director- AAV/Exosome gene therapy at Evox Therapeutics Ltd and Scientific Director at Freeline Therapeutics Limited. Azadeh has a PhD in Molecular Medicine from Imperial College London and a Master of Science in Molecular Biology from the University of Hertfordshire.
May, 2023 - present